Epilepsy Currents最新文献

Playing Multiple Parts: Unique Enzymatic and Structural Roles Orchestrated by SYNGAP1. 发挥多重作用：由SYNGAP1编排的独特酶和结构作用。

IF 6.3 2区医学

Epilepsy Currents Pub Date : 2025-09-30 DOI: 10.1177/15357597251377615

Gordon F Buchanan

引用次数: 0

Resistance is not Futile: Common Genetic Factor Identified for Drug-Resistant Focal Epilepsy. 耐药性不是徒劳的：确定耐药性局灶性癫痫的共同遗传因素。

IF 6.3 2区医学

Epilepsy Currents Pub Date : 2025-09-21 DOI: 10.1177/15357597251377602

Edward Glasscock

引用次数: 0

Fire and Ice: Who's the Main Character in FCDII Pathogenesis? 火与冰：谁是FCDII发病机制的主角？

IF 6.3 2区医学

Epilepsy Currents Pub Date : 2025-09-15 DOI: 10.1177/15357597251377606

Tong Pan, Louis T Dang

引用次数: 0

Don't Sleep on It: The Prognostic Value of Electroencephalography (EEG) Spindles in the Critically ill. 不要睡不着觉：脑电图（EEG）纺锤波对危重病人的预后价值。

IF 6.3 2区医学

Epilepsy Currents Pub Date : 2025-09-15 DOI: 10.1177/15357597251370335

Vineet Punia

引用次数: 0

Epilepsy Readmissions: The More Things Change the More They Stay the Same. 癫痫再入院：变化越多，它们就越保持不变。

IF 6.3 2区医学

Epilepsy Currents Pub Date : 2025-09-11 DOI: 10.1177/15357597251372035

Katherine Noe

引用次数: 0

The Midline Thalamus: The New Kid in Town for Absence Seizure Therapy. 中线丘脑：缺席癫痫治疗的新成员。

IF 6.3 2区医学

Epilepsy Currents Pub Date : 2025-09-01 DOI: 10.1177/15357597251372049

Jeffrey H Goodman

引用次数: 0

Knockdown-Replace: A New Dynamic for Treatment of Dynamin-1 Related developmental and epileptic encephalopathy (DEE). 敲低替代：动力蛋白-1相关发育性和癫痫性脑病（DEE）治疗的新动态。

IF 6.3 2区医学

Epilepsy Currents Pub Date : 2025-08-19 DOI: 10.1177/15357597251370432

Jacy L Wagnon

引用次数: 0

The Many Faces of Juvenile Myoclonic Epilepsy. 青少年肌阵挛性癫痫的多面性。

IF 6.3 2区医学

Epilepsy Currents Pub Date : 2025-08-17 DOI: 10.1177/15357597251370308

Rani A Sarkis

引用次数: 0

A Kaleidoscope of Cognitive Vulnerability in Temporal Lobe Epilepsy. 颞叶癫痫认知易感性的万花筒。

IF 6.3 2区医学

Epilepsy Currents Pub Date : 2025-08-13 DOI: 10.1177/15357597251362779

Ifrah Zawar

引用次数: 0

How Soon is Soon Enough? Consideration of Timing and Disease Etiology for microRNAs in Epilepsy. 多快才算快？癫痫中微小rna的时间和疾病病因的考虑。

IF 6.3 2区医学

Epilepsy Currents Pub Date : 2025-08-11 DOI: 10.1177/15357597251366441

Christina Gross, Amanda M McGann, Durgesh Tiwari

{"title":"How Soon is Soon Enough? Consideration of Timing and Disease Etiology for microRNAs in Epilepsy.","authors":"Christina Gross, Amanda M McGann, Durgesh Tiwari","doi":"10.1177/15357597251366441","DOIUrl":"10.1177/15357597251366441","url":null,"abstract":"<p><p>Recurrent spontaneous seizures in epilepsy cause a myriad of structural, circuit-related, and molecular modifications in the brain. The multifaceted molecular changes suggest that wide-reaching epigenetic mechanisms are altered in epilepsy. Indeed, it has been known for more than 15 years that a class of epigenetic regulators called microRNAs-short, noncoding RNAs that control the translation and stability of sometimes hundreds of mRNA targets-are dysregulated after seizures and in epilepsy in human patients and rodent models. Epilepsy-associated microRNAs regulate many different molecular contributors to epilepsy, including ion channels, neuroinflammatory modulators, and proteins critical for neuronal and synaptic structure. In recent years, it has become clear that microRNAs are important at every phase of epilepsy-from the onset of the first seizure to the latent phase and chronic epilepsy. In line with these findings, manipulation of a subset of microRNAs has been shown to alter seizure susceptibility, reduce epileptogenesis, and/or decrease the frequency of spontaneous recurrent seizures in animal models of epilepsy. These studies illustrate the promise of microRNAs as future therapeutic targets in epilepsy and show that specific microRNAs play different regulatory roles depending on the phase and type of epilepsy. In this concise review, we summarize recent findings of microRNAs in epilepsy, emphasizing novel approaches that advance the field. We discuss the insight on underlying mechanisms and disease etiology that can be drawn from these studies and highlight the importance of timing when developing microRNA-based therapeutic strategies.</p>","PeriodicalId":11742,"journal":{"name":"Epilepsy Currents","volume":" ","pages":"15357597251366441"},"PeriodicalIF":6.3,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339476/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144845050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0